289 related articles for article (PubMed ID: 25079577)
1. Late-onset Zellweger spectrum disorder caused by PEX6 mutations mimicking X-linked adrenoleukodystrophy.
Tran C; Hewson S; Steinberg SJ; Mercimek-Mahmutoglu S
Pediatr Neurol; 2014 Aug; 51(2):262-5. PubMed ID: 25079577
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of PEX6 mutations in Zellweger syndrome spectrum patients.
Ebberink MS; Kofster J; Wanders RJ; Waterham HR
Hum Mutat; 2010 Jan; 31(1):E1058-70. PubMed ID: 19877282
[TBL] [Abstract][Full Text] [Related]
3. [Zellweger syndrome caused by PEX6 gene variation in 2 cases and literature review].
Yang P; Zeng CZ; Tao XW; Rong SW; Long Y; Zeng LK
Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):43-48. PubMed ID: 38154976
[No Abstract] [Full Text] [Related]
4. Absence of biochemical evidence at an early age delays diagnosis in a patient with a clinically severe peroxisomal biogenesis disorder.
Lüsebrink N; Porto L; Waterham HR; Ferdinandusse S; Rosewich H; Kurlemann G; Kieslich M
Eur J Paediatr Neurol; 2016 Mar; 20(2):331-335. PubMed ID: 26700162
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients.
Krause C; Rosewich H; Thanos M; Gärtner J
Hum Mutat; 2006 Nov; 27(11):1157. PubMed ID: 17041890
[TBL] [Abstract][Full Text] [Related]
6. Multivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients.
Zhu Z; Genchev GZ; Wang Y; Ji W; Zhang X; Lu H; Sriswasdi S; Tian G
Orphanet J Rare Dis; 2023 May; 18(1):102. PubMed ID: 37189159
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report.
Blomqvist M; Ahlberg K; Lindgren J; Ferdinandusse S; Asin-Cayuela J
J Med Case Rep; 2017 Aug; 11(1):218. PubMed ID: 28784167
[TBL] [Abstract][Full Text] [Related]
8. Temperature-sensitive mutation of PEX6 in peroxisome biogenesis disorders in complementation group C (CG-C): comparative study of PEX6 and PEX1.
Imamura A; Shimozawa N; Suzuki Y; Zhang Z; Tsukamoto T; Fujiki Y; Orii T; Osumi T; Wanders RJ; Kondo N
Pediatr Res; 2000 Oct; 48(4):541-5. PubMed ID: 11004248
[TBL] [Abstract][Full Text] [Related]
9. Mild Zellweger syndrome due to a novel PEX6 mutation: correlation between clinical phenotype and in silico prediction of variant pathogenicity.
Rydzanicz M; Stradomska TJ; Jurkiewicz E; Jamroz E; Gasperowicz P; Kostrzewa G; Płoski R; Tylki-Szymańska A
J Appl Genet; 2017 Nov; 58(4):475-480. PubMed ID: 29047053
[TBL] [Abstract][Full Text] [Related]
10. Induced pluripotent stem cell models of Zellweger spectrum disorder show impaired peroxisome assembly and cell type-specific lipid abnormalities.
Wang XM; Yik WY; Zhang P; Lu W; Huang N; Kim BR; Shibata D; Zitting M; Chow RH; Moser AB; Steinberg SJ; Hacia JG
Stem Cell Res Ther; 2015 Aug; 6():158. PubMed ID: 26319495
[TBL] [Abstract][Full Text] [Related]
11. Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia.
Chen YJ; Wang MW; Dong EL; Lin XH; Wang N; Zhang ZQ; Lin X; Chen WJ
Parkinsonism Relat Disord; 2019 Aug; 65():256-260. PubMed ID: 31227335
[TBL] [Abstract][Full Text] [Related]
12. A common PEX1 frameshift mutation in patients with disorders of peroxisome biogenesis correlates with the severe Zellweger syndrome phenotype.
Maxwell MA; Nelson PV; Chin SJ; Paton BC; Carey WF; Crane DI
Hum Genet; 1999; 105(1-2):38-44. PubMed ID: 10480353
[TBL] [Abstract][Full Text] [Related]
13. Novel PEX1 coding mutations and 5' UTR regulatory polymorphisms.
Maxwell MA; Leane PB; Paton BC; Crane DI
Hum Mutat; 2005 Sep; 26(3):279. PubMed ID: 16088892
[TBL] [Abstract][Full Text] [Related]
14. Clinical and Biochemical Pitfalls in the Diagnosis of Peroxisomal Disorders.
Klouwer FC; Huffnagel IC; Ferdinandusse S; Waterham HR; Wanders RJ; Engelen M; Poll-The BT
Neuropediatrics; 2016 Aug; 47(4):205-20. PubMed ID: 27089543
[TBL] [Abstract][Full Text] [Related]
15. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
16. Disruption of a PEX1-PEX6 interaction is the most common cause of the neurologic disorders Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease.
Geisbrecht BV; Collins CS; Reuber BE; Gould SJ
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8630-5. PubMed ID: 9671729
[TBL] [Abstract][Full Text] [Related]
17. Zellweger syndrome - a lethal peroxisome biogenesis disorder.
Rafique M; Zia S; Rana MN; Mostafa OA
J Pediatr Endocrinol Metab; 2013; 26(3-4):377-9. PubMed ID: 23327810
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel mutations and sequence variation in the Zellweger syndrome spectrum of peroxisome biogenesis disorders.
Yik WY; Steinberg SJ; Moser AB; Moser HW; Hacia JG
Hum Mutat; 2009 Mar; 30(3):E467-80. PubMed ID: 19105186
[TBL] [Abstract][Full Text] [Related]
19. [Zellweger syndrome, neonatal adrenoleukodystrophy or infantile Refsum's disease in a case with generalized peroxisome defect?].
Schmitt K; Molzer B; Stöckler S; Tulzer G; Tulzer W
Wien Klin Wochenschr; 1993; 105(11):320-2. PubMed ID: 7687405
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
